ASX:MR1 Montem Resources (MR1) Stock Price, News & Analysis → Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad) Free MR1 Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Montem Resources alerts: Email Address Ad Behind the MarketsTiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.Find out more here >>> About Montem ResourcesMontem Resources Limited operates as a steelmaking coal and renewable energy development company in Canada. It owns interests in the Tent Mountain mine re-start project; Chinook project; and Greenfield projects comprising Isola, 4-Stack, and Oldman properties, which are located in the Crowsnest Pass area of southwest Alberta and southeast British Columbia. Montem Resources Limited was incorporated in 2017 and is based in South Melbourne, Australia.Read More Ad DTIBiden’s $374B Giveaway Into This SectorBiden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right hereClick here for the full story MR1 Stock News HeadlinesNo headlines for this company have been tracked by MarketBeat.com Receive MR1 Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Montem Resources and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeASX SectorBasic Materials Industry Coking Coal Sub-IndustryN/A Current SymbolASX:MR1 CUSIPN/A CIKN/A Webmontem-resources.com Phone61 3 9692 7222FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)A($0.07) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-15,800,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-70.63% Return on Assets-14.76% Debt Debt-to-Equity Ratio0.86 Current Ratio1.15 Quick Ratio1.16 Sales & Book Value Annual Sales$159,191.00 Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book ValueA$0.06 per share Price / BookN/AMiscellaneous Outstanding Shares322,830,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta1.40 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report Key ExecutivesMr. Peter Charles DoyleCEO, MD & DirectorMr. Robert James Tindall B.A.Founder & Non-Exec. DirectorMs. Melanie Jaye Leydin B.Bus (Age 50)C.A., CA, CFO & Company Sec. Comp: $129.89kMr. Robert W. Bell (Age 65)Chief Commercial Officer Comp: $303.09kKey CompetitorsAdvance MetalsASX:AVMAJ Lucas GroupASX:AJLAllegiance CoalASX:AHQAnglo Pacific GroupOTCMKTS:AGPIFAspire MiningASX:AKMView All Competitors This page (ASX:MR1) was last updated on 4/20/2024 by MarketBeat.com Staff From Our PartnersThe “Perfect Storm” for GoldGold Safe ExchangeTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsSHOCKING Crypto Leak…Crypto 101 MediaThe #1 Crypto for 2024InvestorPlaceBiden’s $374B Giveaway Into This SectorDTIDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingThe "Smart Money" Is Ready for May 1st Are You?Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Montem Resources Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.